In the last trading session, 3.73 million Evolent Health Inc (NYSE:EVH) shares changed hands as the company’s beta touched 1.49. With the company’s per share price at $14.44 changed hands at -$0.69 or -4.56% during last session, the market valuation stood at $1.68B. EVH’s last price was a discount, traded about -142.38% off its 52-week high of $35.00. The share price had its 52-week low at $13.31, which suggests the last value was 7.83% up since then. When we look at Evolent Health Inc’s average trading volume, we note the 10-day average is 4.06 million shares, with the 3-month average coming to 2.41 million.
Analysts gave the Evolent Health Inc (EVH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.24. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended EVH as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Evolent Health Inc’s EPS for the current quarter is expected to be 0.38.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Evolent Health Inc (NYSE:EVH) trade information
Instantly EVH was in red as seen at the end of in last trading. With action -38.74%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -56.28%, with the 5-day performance at -38.74% in the red. However, in the 30-day time frame, Evolent Health Inc (NYSE:EVH) is -46.77% down. Looking at the short shares, we see there were 10.9 million shares sold at short interest cover period of 6.55 days.
The consensus price target for the stock as assigned by Wall Street analysts is 43, meaning bulls need an upside of 66.42% from its current market value. According to analyst projections, EVH’s forecast low is 33 with 51 as the target high. To hit the forecast high, the stock’s price needs a -253.19% plunge from its current level, while the stock would need to soar -128.53% for it to hit the projected low.
Evolent Health Inc (EVH) estimates and forecasts
Data shows that the Evolent Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -39.45% over the past 6 months, a 50.57% in annual growth rate that is considerably higher than the industry average of 22.50%. Year-over-year growth is forecast to reach 30.80% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 655.7M. 11 analysts are of the opinion that Evolent Health Inc’s revenue for the current quarter will be 721.03M. The company’s revenue for the corresponding quarters a year ago was 556.05M and 639.65M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 17.90%. The estimates for the next quarter sales put growth at 12.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -13.43%. The 2024 estimates are for Evolent Health Inc earnings to decrease by -21.31%, but the outlook for the next 5-year period is at 30.00% per year.
EVH Dividends
Evolent Health Inc is expected to release its next quarterly earnings report in December.
Evolent Health Inc (NYSE:EVH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.95% of Evolent Health Inc shares while 116.70% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 121.49%. There are 116.70% institutions holding the Evolent Health Inc stock share, with WELLINGTON MANAGEMENT GROUP LLP the top institutional holder. As of 2024-06-30, the company held 9.785% of the shares, roughly 11.17 million EVH shares worth $213.55 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.6862% or 11.06 million shares worth $211.39 million as of 2024-06-30.
